Lifevantage Corp LFVN
We take great care to ensure that the data presented and summarized in this overview for Lifevantage Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LFVN
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny828KShares$13.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA498KShares$8.27 Million0.0% of portfolio
-
Capital Management Corp420KShares$6.98 Million1.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX296KShares$4.92 Million0.0% of portfolio
-
Envestnet Asset Management Inc223KShares$3.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY201KShares$3.34 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA193KShares$3.2 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$1.98 Million0.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX111KShares$1.84 Million0.03% of portfolio
-
Empowered Funds, LLC78.9KShares$1.31 Million0.02% of portfolio
Latest Institutional Activity in LFVN
Top Purchases
Top Sells
About LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
Insider Transactions at LFVN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 16
2024
|
Darwin Lewis Director |
BUY
Open market or private purchase
|
Direct |
227
+0.19%
|
$3,632
$16.0 P/Share
|
Nov 12
2024
|
Carl Aure Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,472
-3.94%
|
$71,136
$13.74 P/Share
|
Nov 07
2024
|
Raymond B Greer Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+6.79%
|
$101,647
$13.43 P/Share
|
Nov 07
2024
|
Cynthia Latham Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+12.29%
|
$101,647
$13.43 P/Share
|
Nov 07
2024
|
Darwin Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+6.31%
|
$101,647
$13.43 P/Share
|
Nov 07
2024
|
Garry Paul Mauro Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+8.38%
|
$101,647
$13.43 P/Share
|
Nov 07
2024
|
Rajendran Anbalagan Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+42.76%
|
$101,647
$13.43 P/Share
|
Nov 07
2024
|
Michael A Beindorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+13.52%
|
$101,647
$13.43 P/Share
|
Nov 07
2024
|
Judd Dayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,819
+18.86%
|
$101,647
$13.43 P/Share
|
Nov 06
2024
|
Steven R Fife President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
38,661
-5.41%
|
$502,593
$13.94 P/Share
|
Oct 01
2024
|
Carl Aure Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,625
-1.86%
|
$31,500
$12.33 P/Share
|
Oct 01
2024
|
Carl Aure Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,401
+1.67%
|
-
|
Oct 01
2024
|
Steven R Fife President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,907
-0.82%
|
$70,884
$12.33 P/Share
|
Oct 01
2024
|
Steven R Fife President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,233
+0.45%
|
-
|
Oct 01
2024
|
Kristen Cunningham Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,233
-2.03%
|
$26,796
$12.33 P/Share
|
Oct 01
2024
|
Kristen Cunningham Chief Sales Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.66%
|
-
|
Oct 01
2024
|
Julie Boyster Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,619
-2.17%
|
$31,428
$12.33 P/Share
|
Oct 01
2024
|
Julie Boyster Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,668
+2.95%
|
-
|
Oct 01
2024
|
Alissa Neufeld General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,802
-2.95%
|
$33,624
$12.33 P/Share
|
Oct 01
2024
|
Alissa Neufeld General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,667
+2.73%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 204K shares |
---|---|
Exercise of conversion of derivative security | 111K shares |
Bona fide gift | 30.9K shares |
Open market or private purchase | 3.32K shares |
Payment of exercise price or tax liability | 154K shares |
---|---|
Bona fide gift | 30.9K shares |